bioRxivGenomicsPreprint
A blended genome and exome sequencing method captures genetic variation in an unbiased, high-quality, and cost-effective manner
Toni A. BoltziD, Benjamin B. ChuiD, Calwing LiaoiD, Julia SealockiD, Robert YeiD, Lerato MajaraiD, Jack M. FuiD, Susan K. ServiceiD, Lingyu ZhaniD, Sarah Elizabeth MedlandiD, Sinéad B. ChapmaniD, Simone RubinacciiD, Matthew T. DeFeliceiD, Jonna GrimsbyiD, Tamrat AbebeiD, Melkam Alemayehu KebedeiD, Fred K. Ashaba, Elizabeth G. AtkinsoniD, Tim B. BigdeliiD, Amanda B Bradway, Harrison BrandiD, Lori Beth ChibnikiD, Abebaw FekaduiD, Michael GatzeniD, Bizu GelayeiD, , Alicia R. MartiniD
- Citations
- 12
Abstract
We deployed the Blended Genome Exome (BGE), a DNA library blending approach that generates low pass whole genome (1-4x mean depth) and deep whole exome (30-40x mean depth) data in a single sequencing run. This technology is cost-effective, empowers most genomic discoveries possible with deep whole genome sequencing, and provides an unbiased method to capture the diversity of common SNP variation across the globe. To evaluate this new technology at scale, we applied BGE to sequence >53,000 samples from the Populations Underrepresented in Mental Illness Associations Studies (PUMAS) Project, which included participants across African, African American, and Latin American populations. We evaluated the accuracy of BGE imputed genotypes against raw genotype calls from the Illumina Global Screening Array. All PUMAS cohorts had R2 concordance [≥]95% among SNPs with MAF[≥]1%, and never fell below [≥]90% R2 for SNPs with MAF<1%. Furthermore, concordance rates among local ancestries within two recently admixed cohorts were consistent among SNPs with MAF[≥]1%, with only minor deviations in SNPs with MAF<1%. We also benchmarked the discovery capacity of BGE to access protein-coding copy number variants (CNVs) against deep whole genome data, finding that deletions and duplications spanning at least 3 exons had a positive predicted value of [~]90%. Our results demonstrate BGE scalability and efficacy in capturing SNPs, indels, and CNVs in the human genome at 28% of the cost of deep whole-genome sequencing. BGE is poised to enhance access to genomic testing and empower genomic discoveries, particularly in underrepresented populations.
- organism: human
- assay: whole-genome sequencing
- assay: whole-exome sequencing
- research focus: variant calling
- research focus: variant effect prediction
- research focus: benchmarking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Blended Genome Exome (BGE) as a Cost Efficient Alternative to Deep Whole Genomes or Arrays
Matthew T. DeFelice, Jonna Grimsby, … Benjamin M. Neale·bioRxiv·Apr 3, 2024
- Evaluation of Whole Exome Sequencing as an Alternative of BeadChip and Whole Genome Sequencing in Human Population Genetic Analysis
Zoltán Maróti, Zsolt Boldogkői, … Tibor Kalmár·BMC GenomicsPeer-reviewed·Oct 29, 2018
- Low-coverage sequencing cost-effectively detects known and novel variation in underrepresented populations
Alicia R. Martin, Elizabeth G. Atkinson, … Zukiswa Zingela·The American Journal of Human GeneticsPeer-reviewed·Mar 25, 2021
- Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants
Aziz Belkadi, Alexandre Bolze, … Laurent Abel·Proceedings of the National Academy of SciencesPeer-reviewed·Apr 28, 2015
- WEGS: a cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genome
Claude Bhérer, Robert J. M. Eveleigh, … Daniel Taliun·npj Genomic MedicinePeer-reviewed·Feb 7, 2024
- A new massively parallel nanoball sequencing platform for whole exome research
Yu Xu, Zhe Lin, … Qiang Gao·BMC BioinformaticsPeer-reviewed·Mar 25, 2019